Does Aetna Cover Depression Treatment in New Hampshire? A 2026 Guide

Last updated: July 18, 2026

If you have Aetna health insurance in New Hampshire and you or a family member is managing depression, understanding your coverage options can help you make informed decisions about care. This guide covers how Aetna typically handles depression treatment in New Hampshire, including formulary tiers, prior authorization requirements, electronic prescribing rules under RSA 318-B:21-a, and mental health parity protections under RSA 417-E:1.

Key facts at a glance: Aetna’s pharmacy benefits in New Hampshire are managed by CVS/Caremark. Standard antidepressants (SSRIs, SNRIs, bupropion, mirtazapine, and TCAs) are non-scheduled medications. NH EPCS rules are entirely inapplicable to these drugs. Only Spravato (esketamine, Schedule III) triggers NH electronic prescribing requirements. RSA 417-E:1 requires parity between mental health and medical/surgical benefits for fully insured commercial plans. Verify your specific benefits before booking.

Ready to connect with a licensed provider? See how Klarity may support your depression treatment →

Aetna Depression Coverage Overview in New Hampshire

Aetna offers commercial health plans in New Hampshire through the individual and employer-sponsored markets. Pharmacy benefits are administered by CVS/Caremark, one of the nation’s largest pharmacy benefit managers. Depression treatment coverage under Aetna plans in New Hampshire may include:

• Outpatient psychiatry and therapy visits
• Prescription antidepressants via the CVS/Caremark formulary
• Telehealth mental health visits (RSA 415-J:2 parity)
• Inpatient and intensive outpatient programs when medically necessary
• Treatment-resistant depression therapies, including Spravato, when criteria are met

Coverage specifics depend on your plan type (HMO, PPO, EPO), your employer’s benefit design, and whether your plan is fully insured (state-regulated) or self-funded (ERISA). Always verify your individual benefits before scheduling care.

CVS/Caremark Antidepressant Formulary. New Hampshire 2026

The table below reflects typical CVS/Caremark commercial formulary placement for common depression medications. Tier placement, prior authorization requirements, and quantity limits may vary by specific plan. Verify your benefits through your Aetna member portal at aetna.com or by calling 1-800-872-3862.

Note: Coverage varies by plan. Verify your specific formulary at aetna.com or call CVS/Caremark at 1-800-552-8159.

NH Electronic Prescribing (EPCS) and Depression Medications

New Hampshire RSA 318-B:21-a requires electronic prescribing for all controlled substances, including Schedule II, III, IV, and V drugs, with limited exceptions. This is one of the broadest EPCS mandates in the country.

For depression treatment specifically:

• SSRIs, SNRIs, bupropion, mirtazapine, TCAs, Trintellix, Auvelity: These medications are not federally scheduled controlled substances. NH RSA 318-B:21-a does not apply to them. A provider may prescribe these medications using a standard written or electronic prescription without any EPCS-specific requirements.
• Spravato (esketamine): Spravato is classified as a Schedule III controlled substance under federal law. Under RSA 318-B:21-a, all Schedule III prescriptions in New Hampshire must be transmitted electronically. In addition, Spravato has a mandatory REMS (Risk Evaluation and Mitigation Strategy) program. The prescribing provider and dispensing clinic must both be REMS-certified, and the medication is administered in-clinic only (not dispensed for home use).

How NH EPCS Compares to Other States

The practical takeaway: most patients seeking depression treatment through Aetna in New Hampshire will never encounter NH EPCS requirements, since virtually all first-line antidepressants are non-scheduled. Spravato is the notable exception, and its REMS program already mandates in-clinic dispensing that effectively satisfies most controlled-substance oversight concerns.

Prior Authorization for Depression Medications Under Aetna / CVS/Caremark

CVS/Caremark applies prior authorization and step therapy requirements primarily to brand-name and specialty antidepressants. Understanding the process can reduce delays in accessing treatment.

When Prior Authorization May Apply

• Brand SSRIs/SNRIs (e.g., brand Lexapro, Effexor XR, Cymbalta): CVS/Caremark typically requires trial of a generic equivalent before approving brand coverage.
• Trintellix (vortioxetine): PA is often required. Step therapy from a generic SSRI or SNRI is typically expected.
• Auvelity (bupropion/dextromethorphan): As a newer agent, PA with step therapy is generally required.
• Spravato (esketamine): PA is required in addition to REMS. Criteria typically include a diagnosis of treatment-resistant depression (TRD) or major depressive disorder with acute suicidal ideation/behavior (MDSI), documented failure of at least two adequate antidepressant trials, and enrollment in the Spravato REMS program.

How to Submit a PA Through Aetna/CVS/Caremark

1. Your prescribing provider initiates the PA through Availity (availity.com) or via the Aetna provider portal at aetna.com/providers.
2. CVS/Caremark processes the pharmacy benefit PA through its clinical team.
3. Standard PA decisions are typically issued within 72 hours; urgent requests may be processed within 24 hours.
4. If denied, you have the right to a formal appeal and, for fully insured plans, an external review through the NH Insurance Department (1-800-852-3416).

Mental Health Parity: RSA 417-E:1 and What It Means for Depression Coverage

New Hampshire’s mental health parity law, RSA 417-E:1, requires that fully insured commercial health plans provide mental health and substance use disorder (MH/SUD) benefits that are no more restrictive than medical and surgical benefits. This is known as the non-quantitative treatment limitation (NQTL) requirement.

What parity means in practice for depression coverage:

• If Aetna allows three specialist visits before requiring a referral for a physical health condition, it cannot impose a stricter limit for psychiatric visits.
• Prior authorization and step therapy requirements for antidepressants must be clinically justified in a manner comparable to requirements applied to medical/surgical drugs.
• Cost-sharing (copays, deductibles) for outpatient therapy visits must be comparable to office visit cost-sharing for physical health.

Important limitation: RSA 417-E:1 applies to fully insured commercial plans regulated by the State of New Hampshire. Self-funded employer plans (governed by ERISA) are not subject to state parity law but must comply with the federal Mental Health Parity and Addiction Equity Act (MHPAEA), enforced by the U.S. Department of Labor.

If you believe Aetna has applied parity-violating restrictions to your depression coverage, you may file a complaint with the NH Insurance Department at 1-800-852-3416 or at nh.gov/insurance.

Telehealth Coverage for Depression Treatment in NH

RSA 415-J:2 requires that New Hampshire health insurers provide coverage for telehealth services on terms no less favorable than in-person services. For depression treatment, this means:

• Psychiatric evaluations and medication management appointments may be conducted via telehealth at parity with in-person cost-sharing.
• Therapy sessions with licensed clinical social workers, psychologists, or counselors are generally covered via telehealth when in-person services would be covered.
• Prescribers may electronically prescribe non-scheduled antidepressants following a telehealth visit, provided the clinical standards for diagnosis and prescribing are met.

Depression Diagnoses Typically Covered Under Aetna Plans

Aetna plans generally provide benefits for medically necessary treatment of the following DSM-5 depressive disorders:

• Major Depressive Disorder (MDD), single episode or recurrent (F32.x / F33.x)
• Persistent Depressive Disorder (dysthymia) (F34.1)
• Postpartum / Perinatal Depression (F53.0)
• Premenstrual Dysphoric Disorder (PMDD) (N94.3)
• Adjustment Disorder with Depressed Mood (F43.21)
• Treatment-Resistant Depression (TRD). Typically classified under MDD but flagged for Spravato criteria
• Major Depressive Disorder with Acute Suicidal Ideation/Behavior (MDSI). Spravato indication

How to Verify Your Aetna Depression Coverage in New Hampshire

1. Log in to your Aetna member portal at aetna.com to access your Summary of Benefits and Coverage (SBC) and formulary.
2. Call Aetna member services at 1-800-872-3862. Ask specifically: “Does my plan require PA for antidepressants? What is the step therapy requirement for brand SSRIs/SNRIs? Is Spravato covered under my plan?”
3. Call CVS/Caremark at 1-800-552-8159 to verify formulary tier and any prior authorization requirements for a specific medication.
4. Ask your provider to submit a benefits verification or PA prior to prescribing specialty medications like Spravato.
5. If you have concerns about coverage denials or parity violations, contact the NH Insurance Department at 1-800-852-3416.

How Klarity Health May Help with Depression Treatment

Klarity Health connects patients with a network of 2,000+ licensed providers across the United States, including in New Hampshire, for telehealth-based depression care. Providers on the Klarity platform may offer:

• Comprehensive depression evaluations
• Antidepressant prescribing and medication management
• Coordination with your existing care team
• Insurance benefit verification support

Coverage varies by plan. Klarity recommends verifying your Aetna benefits before your first appointment to understand your out-of-pocket costs.

See if Klarity may support your depression treatment →

Frequently Asked Questions

Does Aetna cover antidepressants in New Hampshire?

Aetna plans in New Hampshire may cover antidepressants through the CVS/Caremark formulary. Generic SSRIs, SNRIs, bupropion, and mirtazapine are typically placed at Tier 1. 2 with low or no copays. Brand antidepressants and specialty medications like Spravato may require prior authorization or step therapy. Coverage varies by plan. Verify your benefits before filling a prescription.

Does NH EPCS (electronic prescribing) apply to antidepressants?

For most antidepressants. Including all SSRIs, SNRIs, bupropion, mirtazapine, and TCAs. NH EPCS under RSA 318-B:21-a does not apply because these are non-scheduled medications. Only Spravato (esketamine, Schedule III) triggers the NH EPCS requirement for depression medications.

Does Aetna cover Spravato (esketamine) in New Hampshire?

Spravato may be covered under Aetna plans for patients with treatment-resistant depression or MDD with acute suicidal ideation, subject to prior authorization, REMS program enrollment, and step therapy requirements. Because Spravato is a Schedule III controlled substance, NH RSA 318-B:21-a requires electronic prescribing. Contact Aetna at 1-800-872-3862 to verify your specific plan’s coverage.

What is the NH mental health parity law and does it apply to Aetna?

RSA 417-E:1 requires that fully insured commercial Aetna plans provide mental health benefits. Including depression treatment. On parity with medical and surgical benefits. Self-funded employer plans are exempt from state law but must comply with federal MHPAEA. Contact the NH Insurance Department (1-800-852-3416) if you believe your plan has imposed parity-violating restrictions.

Can I see a psychiatrist for depression via telehealth under Aetna in NH?

Yes. RSA 415-J:2 requires Aetna to cover telehealth mental health services on terms no less favorable than in-person services. Psychiatric evaluations and medication management visits for depression may be conducted via telehealth, with cost-sharing at parity with in-person office visits.

What should I do if Aetna denies my antidepressant prior authorization?

You have the right to appeal a PA denial. Your provider can submit a peer-to-peer review or formal appeal through Aetna’s appeals process. For fully insured NH plans, you may also request an external review through the NH Insurance Department at 1-800-852-3416 if the internal appeal is unsuccessful.

Key Contacts

• Aetna Member Services: 1-800-872-3862 | aetna.com
• CVS/Caremark (Pharmacy Benefits): 1-800-552-8159 | caremark.com
• NH Insurance Department: 1-800-852-3416 | nh.gov/insurance
• SAMHSA National Helpline: 1-800-662-4357 (free, confidential, 24/7)
• 988 Suicide and Crisis Lifeline: Call or text 988

Disclaimer: This content is for informational purposes only and does not constitute insurance, legal, or medical advice. Coverage descriptions represent general patterns and may not reflect your specific Aetna plan. Benefits vary by plan type, employer design, and state regulations. Always verify your individual benefits with Aetna before booking care. Coverage is not guaranteed.